PDL BioPharma Inc (NASDAQ:PDLI)

2.49
Delayed Data
As of 3:51pm ET
 -0.015 / -0.60%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line264.5M322.2M332.8M63.7M
 
 
 
 
 
Depreciation5.6M----12.0M
 
 
 
Total Other Cash Flow13.8M-18.8M-57.8M51.4M
 
 
 
 
 
Funds From Operations282.9M283.6M292.3M116.4M
 
 
 
 
 
Funds From/For Other Operating Expenses12.0M-8.6M-9.2M14.7M
 
 
 
 
 
Net Cash Flow - Operating Activities270.9M292.3M301.5M101.7M
 
 
 
 
 
 
InvestingIncrease In Investments-9.9M-1.8M0.00-98.0M
 
 
 
 
Decrease In Investments43.8M3.5M1.9M4.7M
 
 
 
 
 
Capital Expenditures-2.0K-49.0K-9.0K-25.0K
 
 
 
 
 
Fixed Asset Disposal------250.0K
 
 
Net Assets From Acquisitions -------109.9M
 
 
Other Investing - Uses-148.7M-230.0M-35.2M-9.0M
 
 
 
 
 
Other Investing - Sources58.1M171.3M68.6M127.2M
 
 
 
 
 
Net Cash Flow Investing-298.0M-138.1M-79.6M-144.3M
 
 
 
 
 
 
FinancingShort Term Borrowings74.2M-75.0M100.0M0.00
 
 
 
 
Long Term Borrowings0.00290.2M-607.0K146.8M
 
 
 
 
Long Term Debt Reduction0.00-56.2M-75.0M-25.0M
 
 
 
 
Net Proceeds Stock Sale0.0011.4M0.000.00
 
 
Common Preferred Redeemed0.00-31.0M-220.4M-120.0M
 
 
 
 
Common Dividends-84.0M-96.6M-98.3M-16.6M
 
 
 
 
 
Cash Dividends Paid - Total-84.0M-96.6M-98.3M-16.6M
 
 
 
 
 
Other Sources - Financing22.0K0.000.00--
 
 
Other Uses - Financing--0.000.0014.4M
 
 
Net Cash Flow - Financing-9.8M42.9M-294.3M-29.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-36.9M197.1M-72.5M-71.7M